Dermovate · DIN 02213265 · 0.05% · Cr
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Dermovate · DIN 02213265
Manufacturer: TaroPharma, a Division of Taro Pharmaceuticals Inc.; listing date 1998-05-21
Health Canada: Marketed since 2004-03-29 · brand DERMOVATE CREAM · ATC D07AD01 CLOBETASOL · form Cream · route Topical · ingredients CLOBETASOL PROPIONATE 0.05 % · company Taropharma, a division of taro pharmaceuticals inc. · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02213265)
Source record
DIN 02213265: Dermovate
Raw flags: sec3=Y
Item: 840600061; group id 841; item number 2046; lccId None; manufacturer id TPH
Source form: Cr; strength: 0.05%
Recorded listing: General benefit
Source prices (unrounded): $1.0203; ministry $0.2279
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02213265
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=36952
Interchangeable products
Mylan-Clobetasol · DIN 02024187 · $0.2279
Taro-Clobetasol Cream USP · DIN 02245523 · $0.2279
Teva-Clobetasol · DIN 01910272 · $0.2279
Shortage status: not checked (no credentials)